Pune, India -- (SBWIRE) -- 11/04/2015 -- Browse 84 market data tables and 32 figures spread through 182 pages and in-depth TOC on "Neuromodulation Market"

http://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html

Early buyers will receive 10% customization on this report.

Neuromodulation is a technique that acts directly on nerves or the target area, where the activity of nerves is altered. These alterations are due to the effects produced by electrical stimulation or drug infusion. These devices include small electrodes, which are placed in the brain, spinal cord, or peripheral nerves, and are connected via leads to an implantable pulse generator placed under the skin to generate electrical stimulation in a precise pattern.

The global neuromodulation market is segmented on the basis of technology, application, and region. Based on technology, the market is segmented into internal and external neuromodulation. Internal neuromodulation is further segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES). External neuromodulation is categorized into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES). The spinal cord stimulation (SCS) segment is expected to have the largest share of the global internal neuromodulation market in 2015. On the other hand, the transcutaneous electrical nerve stimulation (TENS) segment is expected to register the largest share of the global external neuromodulation market in 2015.

Get The Sample Copy of This Report@ http://www.marketsandmarkets.com/requestsample.asp?id=921

Based on application, the neuromodulation market is segmented into technology-wise applications such as spinal cord stimulation (chronic pain, failed back surgery, ischemia); deep brain stimulation (Parkinson's disease, tremor, depression, others), sacral nerve stimulation (urine incontinence, fecal incontinence), vagus nerve stimulation (epilepsy, others), gastric electrical stimulation (gastro paresis, obesity), transcutaneous electrical nerve stimulation (treatment resistant depression, others), and transcranial magnetic stimulation (depression, migraine headaches).

The key factors that are expected to spur the growth of this market include rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by players, and expanded target applications and new indications. Moreover, expansion in emerging economies is likely to create significant growth opportunities for players operating in the market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals are likely to pose as deterrents hampering market growth.

On the basis of region, this market is classified into North America, Europe, Asia-Pacific, and rest of the world (RoW).

Talk To Our Research Analysts for More Information:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=921

Some of the major players in the global market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).

About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:
Mr. Rohan
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets